Abstract
There are believed to be more than 1 million individuals worldwide currently with an organ allograft [1], and a further steep increase in numbers is expected in the next decade. The life-enhancing benefits of organ transplantation are undisputed, but come at a cost. Complications from graft-preserving iatrogenic immunosuppression include a significantly increased risk of malignancy. More than 40 primary malignant neoplasms were reported in the first 4,000 patients to undergo renal transplantation [2], and this early observation has been consistently supported by subsequent studies [3-7].
| Original language | English |
|---|---|
| Title of host publication | Cancer Treatment and Research |
| Pages | 75-95 |
| Number of pages | 21 |
| Volume | 146 |
| DOIs | |
| Publication status | Published - 1 Jan 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'The epidemiology of transplant-associated keratinocyte cancers in different geographical regions'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver